Brown adipose tissue (BAT) is a specialized mammalian tissue and a site of adaptive thermogenesis. Although the metabolic functions of brown and white adipocytes are distinct, terminal differentiation of both adipocyte lineages is regulated by wellcharacterized common transcription factors. However, the early stages of adipocyte differentiation and regulation of precursor cells are not well understood. We report here that GATA2 is expressed in brown adipocyte precursors, and its expression is downregulated in a differentiation-dependent manner. Constitutive expression of GATA2 suppressed expression of BAT-specific genes in brown adipocytes, whereas disruption of a GATA2 allele in brown preadipocytes resulted in significantly elevated differentiation and expression of several markers of brown adipogenesis. Collectively, these results show that GATA2 functions to suppress brown adipocyte differentiation, whereas reduction of GATA2 promotes brown adipogenesis.
INTRODUCTION
Brown adipose tissue (BAT) is a specialized mammalian tissue involved in thermoregulation. In this tissue, thermogenesis occurs through the activity of uncoupling protein 1 (UCP1), an inner mitochondrial membrane protein that functions as a proton leak to deregulate ATP synthesis. Morphologically, brown adipocytes store triglycerides as multilocular droplets dispersed throughout the cell amidst numerous mitochondria with dense cristae. BAT hypertrophies in response to prolonged exposure to cold (Bukowiecki et al, 1986) or adrenergic stimulation (Geloen et al, 1992) , and deteriorates in mass and function in obese animals (Himms-Hagen, 1989; Nisoli et al, 2000) .
The sequence of events that regulate formation of BAT during development is poorly understood. Although BAT and white adipose tissue (WAT) are functionally distinct, they share transcriptional regulators that mediate their terminal differentiation (Rosen & Spiegelman, 2000) . Early in the differentiation programme, C/EBPb and C/EBPd are transiently expressed (Cao et al, 1991; Yeh et al, 1995) and contribute to the expression of PPARg (Wu et al, 1995; Darlington et al, 1998) , an indispensable activator of terminal adipocyte differentiation (Rosen et al, 1999) , and C/EBPa, another important transcriptional component of adipogenesis (Rosen et al, 1999; Wu et al, 1999b) . PPARg and C/EBPa operate synergistically to promote the expression of genes found in both adipocyte lineages, such as aP2 fatty-acid-binding protein, fatty acid synthase (FAS), leptin and adiponectin (Rosen & Spiegelman, 2000) . Whereas PPARg can induce differentiation of C/EBPa À/À cells, PPARg À/À cells lack the ability to differentiate (Rosen et al, 1999) . Conversely, C/EBPa À/À cells can be induced to differentiate with PPARg; however, they cannot form functionally intact adipocytes, especially with regard to insulin action and glucose metabolism (Wu et al, 1999b) . Compared with white adipocytes, mature brown adipocytes preferentially express UCP1 and PPARg-coactivator 1 (PGC1a; Ross et al, 1992; Puigserver et al, 1998) . PGC1a is regulated by adrenergic stimulation in brown adipocytes, and transactivates genes associated with mitochondrial biogenesis, respiration and thermogenesis (Puigserver et al, 1998; Wu et al, 1999a) .
Recent studies have indicated a role for the GATA family of transcription factors in white adipogenesis (Tong et al, 2000 (Tong et al, , 2005 Menghini et al, 2005) . In this study, we investigated the function of GATA proteins during brown adipocyte differentiation. Our findings indicate that constitutive expression of GATA2 blocked transcriptional activation and expression of genes specific to the brown lineage as well as some, but not all, common adipogenic molecules. Reduction of GATA2 expression through conditional inactivation of a GATA2 allele in brown preadipocytes resulted in increased expression of several BAT-specific and mitochondrial genes. Taken together, these observations show that GATA2 has a crucial role in brown adipocyte differentiation.
RESULTS AND DISCUSSION
Our laboratory has previously described the role for two members of the GATA transcription factor family in white adipocyte differentiation. Unlike WAT, which expressed both GATA2 and GATA3, BAT expressed only GATA2 and not GATA3 (Fig 1A) . The level of GATA2 expression in BAT is lower than other genes examined in WAT and BAT such as UCP1, aP2 and PPARg ( Fig 1A) . As further controls for gene expression in WAT and BAT, we also measured ATP synthase, cytochrome c oxidase subunits IV and II (COX IV and COX II) and PGC1a (1.1, 2.6-, 5.8-and 22-fold higher in BAT compared with WAT, respectively; Fig 1A) . The expression pattern of GATA factors in BAT was mimicked in brown adipocyte cell lines, in which GATA2 but not GATA3 expression was detectable (Fig 1B) . The highest expression levels of GATA2 gene transcripts were observed in brown preadipocytes before differentiation, and rapidly diminished after the initiation of adipogenesis (Fig 1B) . Proper differentiation of this cell line over a time course was verified by expression of adipogenic genes common to both white and brown cell types, such as aP2 and PPARg, as well as induction of brown adipocyte genes such as UCP1, PGC1a or COX IV (Fig 1B) . C/EBPa expression was also induced by day 2 (5.8-fold) and maintained afterwards, whereas ATP synthase expression was slightly induced (1.5-fold) and remained steady throughout differentiation (not shown). The differentiation-dependent expression pattern of GATA2 can be independently replicated in both the HB2 (Irie et al, 1999) and FVB (Klein et al, 1999) brown adipocyte cell lines (data not shown). GATA2 protein was also detectable in HIB-1B preadipocytes and was suppressed after differentiation of these cells into adipocytes (Fig 1C) .
The decrease in GATA2 is concomitant with an increase in adipogenic gene expression, which suggests that downregulation of GATA2 may be crucial for attaining the mature brown adipocyte phenotype. To test this, we examined the impact of constitutive expression of GATA2 on brown adipocyte differentiation. Retroviral transduction was used to constitutively express GATA2 or the empty vector as controls in several brown adipocyte cell lines (Fig 2A) . The expression levels of exogenous GATA2 messenger RNA and protein were confirmed by reverse transcription-PCR (RT-PCR) and western blotting (Fig 2A; data not shown). Constitutive expression of GATA2 strongly suppressed genes associated with terminally differentiated brown adipocytes such as UCP1, PGC1a and COX IV (Fig 2B) . The expression of COX II was also strongly suppressed (fourfold), but regulation of ATP synthase b-subunit was mild (1.5-fold), as examined by real-time RT-PCR during differentiation of these cells. Although there was also suppression of PPARg and aP2 mRNAs, other adipogenic genes such as C/EBPa and adipsin were expressed at similar levels in control and GATA2-expressing cells (Fig 2B) , which suggests differential regulation of brown versus common adipogenic genes by GATA2.
To determine whether GATA2 has the ability to regulate these genes differentially, we examined the effect of GATA2 on the transcriptional activities of the C/EBPa, UCP1 and PGC1a promoters, which contain putative GATA-binding sites, in HIB-1B preadipocytes. Interestingly, GATA2 had no effect on the transcriptional activity of the C/EBPa promoter ( Fig 2C) . In contrast, the basal activity of both UCP1 (a 2.9 kb 5 0 -flanking region) and PGC1a (a 230 bp 5 0 -flanking region) promoters was suppressed two-to threefold by GATA2 (Fig 2D,E) . These data indicate that GATA2 is not a general suppressor of all promoters expressed in these cells. These results also indicate that GATA2 (A) Expression of GATA2, GATA3 and other brown (UCP1 and PGC1a) or common (PPARg and aP2) adipocyte markers was examined in total RNA samples isolated from interscapular brown adipose tissue (BAT) and epididymal white adipose tissue (WAT), by northern blot analysis.
(B) Expression of GATA2 during brown adipocyte differentiation (induced at day 0). GATA2, GATA3, UCP1, PGC1a, PPARg, aP2 and COX IV (cytochrome c oxidase subunit IV) gene expression was examined by northern blot analysis in HIB-1B cells collected at 2-day intervals during differentiation. Cells are stimulated with isoproterenol for 6 h before collection at each time point. GATA2 and GATA3 panels are exposed overnight, others for 6 h. (C) GATA2 protein in HIB-1B cells in preadipocytes (pre-Ad) and differentiated (4-day) adipocytes (Ad). EtBr, ethidium bromide.
GATA factors and brown adipogenesis J. Tsai et al may act directly on the UCP1 promoter, or that the effect on UCP1 is secondary to the suppression of PGC1a. To address the latter, we tested whether GATA2-mediated suppression of UCP1 expression could be rescued by exogenous PGC1a. Ectopic expression of PGC1a in GATA2-expressing cells failed to restore suppression of gene expression by constitutive GATA2 expression, most strikingly for UCP1 ( Fig 2F) . As before, the impact on suppression of PPARg and aP2 was modest, but these, too, were not enhanced by coexpression of PGC1a with GATA ( Fig 2F) . Therefore, it is likely that GATA2 regulates UCP1 and perhaps other brown adipocyte target genes independent of the suppression of PGC1a. Alternatively, it is also possible that GATA2 interacts directly with PGC1a or another protein of functional significance, to alter either its activity or access to its transcriptional targets. For example, GATA proteins have been shown to bind directly to C/EBP transcription factors and interfere with their activity in white adipocytes (Tong et al, 2005) . Thus, it will be of interest to examine whether such interactions also exist for other molecules that are crucial in the differentiation or function of brown and white adipocytes such as PGC1a. Finally, much higher levels of exogenous PGC1a might be necessary to reverse the effects of GATA in brown adipocytes. Interestingly, constitutive GATA expression had virtually no effect on the expression of the transcriptional regulator C/EBPa (Fig 2B) , and also did not influence the transcriptional activity of a 1.6 kb C/EBPa promoter (Fig 2D) . This suggests a biased regulation of brown adipocyte genes compared with those associated with general adipocyte differentiation. Consistent with this, overexpression of GATA2 did not significantly affect the lipid accumulation that is typically associated with adipocyte maturation (Fig 3A) . Ectopic expression of GATA3 also resulted in a similar profile, with little impact on adipocyte morphology (Fig 3A) . This might be the cumulative result of intact C/EBPa expression and/or residual PPARg action in these cells. Conversely, the structural integrity of mitochondria was compromised in GATA2-expressing cells, as reflected by the decreased density of cristae shown by electron microscopy (Fig 3B) . Taken together, our results are consistent with the ability of GATA2, which is native to the Gene expression patterns in GATA-expressing (at day 6) or vector-expressing (at days 0 and 6) HIB-1B cells after stimulation with isoproterenol for 6 h before collection. Ethidium bromide (EtBr) staining was included to reflect loading and integrity of RNA. (C-E) Relative luciferase activities of 1.6 kb C/EBPa, 2.9 kb UCP1 and 230 bp PGC1a promoters in the presence or absence of GATA2 in HIB-1B preadipocytes. UCP1 promoter activity was measured in the presence of exogenous PGC1 for activation. (F) Coexpression of PGC1a (Pa) and GATA2 in HIB-1B cells. Cells were differentiated and total RNA was isolated for analysis of PPARg and aP2 gene expression.
GATA factors and brown adipogenesis J. Tsai et al brown adipocyte, to selectively block features of brown adipocyte differentiation. A GATA2 À/À embryonic stem (ES) cell-culture system is not feasible for the study of brown adipocyte differentiation because of the difficulty of obtaining a consistent and stable phenotype representing brown adipocytes (J.T. & G.S.H., unpublished observations). Thus, to examine whether the progression of brown adipogenesis could be altered by the loss of GATA2 in preadipocytes, we generated a brown adipocyte cell line using primary brown adipocytes from animals that harbour one conditional loxB allele of GATA2 (G2LoxB; Fig 4A; Chang et al,  2002) . Subsequently, we exogenously expressed Cre recombinase to induce a targeted deletion of the GATA2 allele in these cells (DGATA2) and examined their ability to differentiate and support brown adipocyte gene expression profiles. As shown in Fig 4B,C , GATA2 mRNA and protein expressions were significantly reduced in DGATA2 cells, indicating the efficacy of the experimental procedure. In comparison with their control counterparts, DGATA2 brown adipocytes with reduced GATA2 expressed significantly higher levels of BAT-specific genes after differentiation, such as UCP1 and PGC1a (Fig 4D) . Reduction of GATA2 gene expression also resulted in increased expression of GATA factors and brown adipogenesis J. Tsai et al mitochondrial genes such as COX IV, COX II and ATP synthase (Fig 4E) . There was a 1.8-fold increase in PPARg expression in DGATA2 cells compared with controls. These conditions also mildly enhanced cellular capacity for differentiation, as indicated by greater intracellular lipid accumulation (Fig 4F) . We also attempted to determine whether GATA2 has a role in the formation of BAT in chimeric mice produced by GATA2 À/À ES cells. Analysis of tissues from these chimeric animals indicated that GATA2 À/À cells were not excluded from BAT or WAT (not shown). Although the chimaera analysis should be interpreted cautiously because of the limitations of that system, together with our cell-based experiments, these data indicate that GATA2 is not required for white or brown adipogenesis; however, its reduced expression in precursor cells potentiates brown adipocyte differentiation. Several lines of evidence have indicated an important role for BAT in metabolic homeostasis (Himms-Hagen, 1989; Lowell et al, 1993; Guerra et al, 2001) . Mechanisms that regulate the formation and function of this tissue may also contribute to overall energy balance (Kopecky et al, 1995; Guerra et al, 2001) . Hence, one possible function of GATA2 in brown adipocytes may be to modulate brown adipocyte differentiation in response to the changing metabolic demands of the organism. It will be of interest to investigate further whether GATA serves as a metabolic 'fulcrum', in which it activates energy dissipation versus storage by gating brown and white adipocyte differentiation. Other transcription factors have also been shown to function in such a capacity. Of particular note are FOXC2, SRC1, TIF2, PTEN and RIP140, all of which have significant roles in mediating energy balance and fuel metabolism at the molecular level through transcriptional regulation (Cederberg et al, 2001; Picard et al, 2002; Wang et al, 2003; Komazawa et al, 2004; Leonardsson et al, 2004) . The possible interaction of GATA proteins with these molecules has yet to be fully determined. In addition, its early expression in preadipocytes suggests a possible role in cell-lineage determination, as has been described for Retinoblastoma (Hansen et al, 2004) . In vivo manipulation of GATA2 expression, specifically in the preadipocytes of adipose tissue, will further our understanding of this potential role.
METHODS
Cell culture. HIB-1B and HB2 cells were cultured as described previously (Ross et al, 1992; Irie et al, 1999) , with minor modifications (see the supplementary information online). Primary cells were isolated from transgenic animals as described previously (Irie et al, 1999) . RNA isolation and analysis, western blots. Total RNA was extracted using TRIzol s (Invitrogen, Carlsbad, CA, USA) and then analysed either by northern blot analysis or real-time RT-PCR, as described previously (Maeda et al, 2005) . To study the expression, both endogenous and exogenous GATA2 mRNA expression primers common to human and mouse sequences were used. GATA2 antibodies were obtained from Santa Cruz (Santa Cruz, CA, USA) and Cell Signaling (Beverly, MA, USA) and 200 mg total cellular protein extract was used to examine GATA2 expression. Viral transfections. For retroviral transduction, stable transfectants were generated as described previously (Xu et al, 1999) , with minor modifications. To generate DGATA2 cell lines, immortal GATA2 flox/ þ p53 À/À brown adipocytes obtained from the above procedure were infected with the AdCMV-Cre adenovirus (provided by Randy Johnson, UCSD, San Diego, CA, USA), as described in the supplementary information online. Luciferase assays. The luciferase reporter constructs directed by C/EBPa, PGC1a and UCP1 5 0 -flanking sequences were provided by M. Daniel Lane (Johns Hopkins University, Baltimore, MD, USA), Marc Montminy (Salk Institute for Biological Studies, La Jolla, CA, USA) and Leslie Kozak (Pennington Biomedical Research Center, Baton Rouge, LA, USA). For experimental details, see the supplementary information online. Oil red O staining. Differentiated adipocytes were fixed with 0.5% glutaraldehyde in phosphate-buffered saline (PBS), stained with 0.5% (w/v) oil red O stain (Sigma, St Louis, MO, USA) and visualized by standard light microscopy at Â40 magnification. Electron microscopy. Differentiated HIB-1B cells expressing either GATA2 or vector control were trypsinized, pelleted at 1,500 r.p.m. for 5 min, washed with PBS at pH 7.0 and pelleted again at 1,500 r.p.m. for 5 min. Cells were processed for electron microscopy as described previously (Stearns et al, 2001) , with minor modifications (see the supplementary information online). Supplementary information is available at EMBO reports online (http://www.emboreports.org).
